Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: A retrospective cohort study

Blood

Volumn 119, Issue 9, 2012, Pages 2141-2148

  Kanda, Junya ^a   Hishizawa, Masakatsu ^a   Utsunomiya, Atae ^b   Taniguchi, Shuichi ^c   Eto, Tetsuya ^d   Moriuchi, Yukiyoshi ^e   Tanosaki, Ryuji ^f   Kawano, Fumio ^g   Miyazaki, Yasushi ^h   Masuda, Masato ⁱ   Nagafuji, Koji ^j   Hara, Masamichi ^k   Takanashi, Minoko ^l   Kai, Shunro ^m   Atsuta, Yoshiko ⁿ   Suzuki, Ritsuro ⁿ   Kawase, Takakazu ^o   Matsuo, Keitaro ^o   Nagamura Inoue, Tokiko ^p   Kato, Shunichi ^q   Sakamaki, Hisashi ^r   Morishima, Yasuo ^o   Okamura, Jun ^s   Ichinohe, Tatsuo ^a   Uchiyama, Takashi ^a   more..

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Imamura Bun in Hospital   (Japan)

^c TORANOMON HOSPITAL   (Japan)

^d HAMANOMACHI HOSPITAL   (Japan)

^e Sasebo Shiritsu Sogo Hospital   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL   (Japan)

^g NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

^h NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

ⁱ UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

^j KYUSHU UNIVERSITY   (Japan)

^k EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^l Tokyo Metropolitan West Red Cross Blood Center   (Japan)

^m HYOGO COLLEGE OF MEDICINE   (Japan)

ⁿ NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^o AICHI CANCER CENTER HOSPITAL   (Japan)

^p UNIVERSITY OF TOKYO   (Japan)

^q TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^r TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^s NATIONAL KYUSHU CANCER CENTER   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; DISEASE COURSE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; T CELL LEUKEMIA; TREATMENT OUTCOME;

EID: 84857779288     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-07-368233     Document Type: Article

References (45)

1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977; 50(3):481-492. (Pubitemid 8180432)
2. Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol. 1997;15:15-37. (Pubitemid 27169273)
3. Verdonck K, Gonzalez E, van Dooren S, Vandamme AM, Vanham G, Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis. 2007;7(4): 266-281. (Pubitemid 46414075)
4. Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7(4):270-280. (Pubitemid 46480972)
5. Arisawa K, Soda M, Endo S, et al. Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer. 2000;85(3): 319-324. (Pubitemid 30030402)
6. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemialymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991;79(3):428-437.
7. Yamada Y, Tomonaga M, Fukuda H, et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol. 2001;113(2):375-382. (Pubitemid 32523141)
8. Tsukasaki K, Utsunomiya A, Fukuda H, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol. 2007;25(34):5458-5464. (Pubitemid 350232223)
9. Bazarbachi A, Ghez D, Lepelletier Y, et al. New therapeutic approaches for adult T-cell leukaemia. Lancet Oncol. 2004;5(11):664-672. (Pubitemid 40267851)
10. Kchour G, Tarhini M, Kooshyar MM, et al. Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL). Blood. 2009;113(26): 6528-6532.
11. Yamamoto K, Utsunomiya A, Tobinai K, et al. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol. 2010;28(9): 1591-1598.
12. Jabbour M, Tuncer H, Castillo J, et al. Hematopoietic SCT for adult T-cel leukemia/lymphoma: a review. Bone Marrow Transplant. 2011;46(8): 1039-1044.
13. Utsunomiya A, Miyazaki Y, Takatsuka Y, et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001; 27(1):15-20. (Pubitemid 32124402)
14. Kami M, Hamaki T, Miyakoshi S, et al: Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma. Br J Haematol. 2003;120(2):304-309. (Pubitemid 36194182)
15. Fukushima T, Miyazaki Y, Honda S, et al: Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia. 2005;19(5):829-834. (Pubitemid 40663104)
16. Okamura J, Utsunomiya A, Tanosaki R, et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/ lymphoma. Blood. 2005;105(10):4143-4145. (Pubitemid 40656167)
17. Nakase K, Hara M, Kozuka T, Tanimoto K, Nawa Y. Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphoma. Bone Marrow Transplant. 2006;37(1):41-44. (Pubitemid 43135313)
18. Kato K, Kanda Y, Eto T, et al. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program. Biol Blood Marrow Transplant. 2007;13(1):90-99. (Pubitemid 46044093)
19. Yonekura K, Utsunomiya A, Takatsuka Y, et al. Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008; 41(12):1029-1035. (Pubitemid 352034178)
20. Shiratori S, Yasumoto A, Tanaka J, et al. A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versusleukemia/lymphoma effect. Biol Blood Marrow Transplant. 2008;14(7):817-823. (Pubitemid 351773158)
21. van Besien KW, de Lima M, Giralt SA, et al. Management of lymphoma recurrence after allogeneic transplantation: the relevance of graftversus-lymphoma effect. Bone Marrow Transplant. 1997;19(10):977-982. (Pubitemid 27232173)
22. Tanosaki R, Uike N, Utsunomiya A, et al. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome. Biol Blood Marrow Transplant. 2008;14(6):702-708. (Pubitemid 351681417)
23. Hishizawa M, Kanda J, Utsunomiya A, et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood. 2010;116(8):1369-1376.
24. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15(6):825-828.
25. Sullivan KM, Agura E, Anasetti C, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol. 1991;28(3):250-259.
26. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18(6):695-706. (Pubitemid 29126745)
27. Fine JP, Gray RJ. A proportional hazards model for subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
28. Cortese G, Andersen P. Competing risks and time-dependent covariates. Biom J. 2010;52(1): 138-158.
29. Giralt S, Ballen K, Rizzo D, et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2009;15(3):367-369.
30. Atsuta Y, Suzuki R, Yamamoto K, et al. Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation. Bone Marrow Transplant. 2006;37(3):289-296.
31. Ozawa S, Nakaseko C, Nishimura M, et al. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program. Br J Haematol. 2007;137(2):142-151. (Pubitemid 46474715)
32. Nagafuji K, Matsuo K, Teshima T, et al. Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japanese Society for Hematopoietic Stem Cell Transplantation registry. Int J Hematol. 2010;91(5):855-864.
33. Gratwohl A, Brand R, Apperley J, et al. Graftversus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood. 2002;100(12):3877-3886. (Pubitemid 35396852)
34. Kanda Y, Izutsu K, Hirai H, et al. Effect of graftversus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate. Leukemia. 2004;18(5):1013- 1019.
35. Harashima N, Kurihara K, Utsunomiya A, et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res. 2004;64(1):391-399. (Pubitemid 38114123)
36. Tanaka Y, Nakasone H, Yamazaki R, et al. Single-cell analysis of T-cell repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma. Cancer Res. 2010;70(15):6181- 6192.
37. Franchini G, Wong-Staal F, Gallo RC. Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of patients with adult T-cell leukemia. Proc Natl Acad Sci U S A. 1984;81(19): 6207-6211. (Pubitemid 15220809)
38. Kinoshita T, Shimoyama M, Tobinai K, et al. Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci U S A. 1989;86(14):5620-5624. (Pubitemid 19185596)
39. Choi I, Tanosaki R, Uike N, et al. Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials. Bone Marrow Transplant. 2011;46(1):116-118.
40. Yamasaki R, Miyazaki Y, Moriuchi Y, et al. Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma. Leukemia. 2007; 21(6):1212-1217. (Pubitemid 46831810)
41. Le Gouill S, Milpied N, Buzyn A, et al. Graftversus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Française de Greffe de Moëlle et de Thérapie Cellulaire. J Clin Oncol. 2008;26(14):2264-2271.
42. Duarte RE, Canals C, Onida F, et al. Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sezary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol. 2010;28(29): 4492-4499.
43. Hishizawa M, Imada K, Ishikawa T, Uchiyama T. Kinetics of proviral DNA load, soluble interleukin-2 receptor level and tax expression in patients with adult T-cell leukemia receiving allogeneic stem cell transplantation. Leukemia. 2004;18(1): 167-169. (Pubitemid 38159454)
44. Hishizawa M, Imada K, Sakai T, et al. Antibody responses associated with the graft-versus-leukemia effect in adult T-cell leukemia. Int J Hematol. 2006;83(4):351-355. (Pubitemid 43807582)
45. Kawahara M, Hori T, Matsubara Y, et al. Cyclin-dependent kinaselike 5 is a novel target of immunotherapy in adult T-cell leukemia. J Immunother. 2007;30(5):499-505. (Pubitemid 46988083)